Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
Provided By GlobeNewswire
Last update: Mar 31, 2025
Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ongoing and first prescriptions filled
Read more at globenewswire.com1.83
-0.01 (-0.54%)
FORTRESS BIOTECH INC - FBIO 9 3/8 PERP
NASDAQ:FBIOP (6/17/2025, 4:30:02 PM)
8.712
+0.03 (+0.33%)
Find more stocks in the Stock Screener
